Statins and Dementia

Published in: Archives of Neurology, v. 58, no. 7, Editorial, July 2001, p. 1169-1170

Posted on on December 31, 2000

by Beatrice A. Golomb, Beth Jaworski

Read More

Access further information on this document at

This article was published outside of RAND. The full text of the article can be found at the link above.

Use of statin cholesterol-lowering drugs is observationally associated with lower rates of Alzheimer disease (AD). The authors make an even stronger point: data are consistent with and indeed can be taken to support the contrary conclusion--that high cholesterol protects against dementia. Lipid-lowering drugs are used in the context of--and may serve statistically as a marker for--elevated cholesterol.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.